Investigator sought to determine whether nelfinavir mesylate plus chemoradiation and image-guided brachytherapy could improve disease-free survival for patients with stage III cervical cancer.
Nxera Pharma UK Ltd. has divulged 3C-like proteinase (3CLpro; Mpro; nsp5) (SARS-CoV-2; COVID-19 virus) inhibitors reported to be useful for the treatment of SARS-CoV-2 infection (COVID-19).
Tohoku University has disclosed 3C-like proteinase (3CLpro; Mpro; nsp5) (SARS-CoV-2; COVID-19 virus) inhibitors reported to be useful for the treatment of viral infections and inflammatory disorders.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results